Hamlet Pharma enters into Patent Licensing Agreement
A patent licensing agreement has been signed between Hamlet Pharma AB and Linnane Pharma AB to secure the development and commercialisation of BAMLET for use other than as a pharmaceutical.Today, Hamlet Pharma AB has signed a patent licensing agreement with Linnane Pharma AB for the development of BAMLET; a complex formed by bovine alpha-lactalbumin and oleic acid. Hamlet Pharma AB retains the rights to develop BAMLET as a pharmaceutical but licenses to Linnane Pharma AB the rights to develop BAMLET for other, non-pharmaceutical purposes. The agreement stipulates that Linnane Pharma AB will